Worldwide Life Sciences R&D Pharmacovigilance Technology Solutions and Consulting Services

PwC has been named as a Leader in the IDC MarketScape: Worldwide Life Sciences R&D Pharmacovigilance Technology Solutions and Consulting Services 2025 Vendor Assessment (July 2025, IDC #US53669225). 
 
As per the above report, ‘The real goal of the life sciences industry is to ensure a consistent positive benefit-risk profile for the drugs that it manufactures. However, this is not an easy task as organizations struggle with fragmented data sources, latency issues, and more.’ 

Commenting on PwC, the IDC MarketScape report states, ‘PwC provides pharmacovigilance (PV) consulting services to customers ranging from small biotechs to the top 10 pharma. PwC has a dedicated workforce transformation team with experience in PV organizational design, business process transformation, and business enablement. It has a dedicated technology and transformation team. It has helped a client that was launching its first commercial product better understand the gaps in its PV systems. PwC has a dedicated risk and regulatory team, which includes ex-FDA and ex-EMA regulatory experts, with experience in designing risk management activities, including RMPs and REMS, benefit-risk assessments, and in preparing for inspections. It also provides a series of multivigilance services.’ 

On PwC’s strengths, the IDC MarketScape states, “PwC's differentiators include its proprietary, first cloud-native PV platform (hosted on AWS) launched in 2018, which uses AI/ML to automate case processing, and that has passed multiple regulatory inspections, its experience in business strategy and technology implementation across the PV value chain, powering its comprehensive PV consulting services.” 

It goes on to say, ‘Consider PwC when seeking deep experience in business strategy and technology implementation across all aspects of PV, as well as a cloud-based AI/ML-enabled platform that automates case intake and processing, that leverages GenAI for narrative generation, and that has passed FDA and MHRA inspections.’ 

Read the report excerpt here 

About IDC MarketScape

IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of technology and service suppliers in a given market. The research utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of technology suppliers can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.